These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7430882)

  • 1. Tamoxifen suppresses both the growth of prolactin-secreting pituitary tumours and normal prolactin synthesis in the rat.
    de Quijada M; Timmermans HA; Lamberts SW
    J Endocrinol; 1980 Jul; 86(1):109-16. PubMed ID: 7430882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    J Endocrinol; 1983 May; 97(2):261-6. PubMed ID: 6854193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
    Nagy I; Valdenegro CA; MacLeod RM
    Neuroendocrinology; 1980 Jun; 30(6):389-95. PubMed ID: 7383277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
    Lamberts SW; Verleun T; Oosterom R
    Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats.
    Vrontakis ME; Thliveris JA; Friesen HG
    J Endocrinol; 1987 Jun; 113(3):383-8. PubMed ID: 3625096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin secretion in rats bearing a prolactin-secreting pituitary tumor: effects of naloxone administration.
    Lamberts SW; Zuiderwijk JM; Bons EG; Uitterlinden P; de Jong FH
    Fertil Steril; 1981 May; 35(5):557-62. PubMed ID: 6785115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia and DNA synthesis in the pituitary gland of the rat.
    Burdman JA; Calabrese MT; MacLeod RM
    J Endocrinol; 1983 Apr; 97(1):65-74. PubMed ID: 6132955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromocriptine and tamoxifen--a new therapeutic approach in suppression-resistant prolactin-secreting adenomas].
    Völker W; Gehring WG; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1982 Nov; 42(11):790-7. PubMed ID: 6924910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
    Kalbermann LE; Machiavelli GA; De Nicola AF; Weissenberg LS; Burdman JA
    J Endocrinol; 1980 Nov; 87(2):221-4. PubMed ID: 7430920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
    Koizumi K; Aono T
    Fertil Steril; 1986 Aug; 46(2):312-4. PubMed ID: 3089843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prolactin secretion and synthesis by dopamine, noradrenaline and pilocarpine in cultured rat pituitary tumour cells.
    Bang S; Gautvik KM
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):317-27. PubMed ID: 411328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin.
    Jordan VC; Koerner S
    J Endocrinol; 1976 Feb; 68(02):305-11. PubMed ID: 815505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired calcium mobilisation in the 7315a prolactin-secreting pituitary tumour.
    Judd AM; Login IS; Jarvis WD; MacLeod RM
    Cell Calcium; 1987 Jun; 8(3):189-96. PubMed ID: 3111713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.